Main PLC Board
Lord Maxwell Beaverbrook Chairman
Lord Beaverbrook, a British peer, baronet, politician and businessman, was born in 1951. He is the grandson of the 1st Baron Beaverbrook (Minister of Aircraft Production 1940-1942) and the only son of Group Captain Sir Max Aitken DSO DFC.
After completing his education at Pembroke College, Cambridge, Lord Beaverbrook worked at Express Newspapers from 1972-1978, rising to General Manager of Sunday Express. From 1978 he served as Director of the Aitken/Beaverbrook Family Office, overseeing a diversified investment fund specialising in real estate, as well as in oil and gas, and insurance. During the same time frame, he also founded VenTech Investments Inc. (Canada) where he served as Executive Chairman.Under Lord Beaverbrook’s direction VenTech Group became the largest home healthcare operator in the US.
After becoming a member of the House of Lords in 1985, Lord Beaverbrook was appointed Government Whip and Junior Minister at the Department of Trade & Industry in 1986.
He was appointed Treasurer of the Conservative Party by Margaret Thatcher in 1990, succeeding Lord McAlpine, following a 2 year period served as Deputy Treasurer. He stepped down after the successful 1992 election campaign.
In 1993, Lord Beaverbrook’s interest in the telecom industry led to the formation of Highway One AG, a broadband, multimedia, data transport company, of which he was Chairman until 1999. The company was sold to Telefonica of Spain, in 2001. From 2000-2007 he was Chairman of Net Integration Technologies Inc of Toronto, now part of IBM. He remains the Chairman of the Beaverbrook/Aitken Family Office, which retains active investments in the UK, Europe and the US.
Lord Beaverbrook was a Director of the British Racing Drivers Club (owners of Silverstone) from 2006-2008, and has been a Director of the British Powerboat Racing Club since 2000. He is active in various charities and is currently a Vice President of the National Association of Boys Club, and the Chairman of the Beaverbrook Foundation, of which he has been a Trustee since 1974. He was a Member of Council, Homeopathic Trust 1987 – 1992.
Lord Beaverbrook is also active in the Royal Auxiliary Air Force (RAF Reserves), where he is Honorary Inspector General in the rank of Air Vice-Marshal
Paul Morton Chief Executive Officer
Prior to joining the company, Paul was with GE Healthcare, where he was Group Commercial Director of the Healthcare Solutions business of GE Healthcare, a $17 billion subsidiary of the General Electric Company.
In that role, he was responsible for growing the company’s Education, Healthcare IT & Technology and consulting divisions in Russia CIS, Turkey, Central Asia, the Middle East and Africa from US$150 million to US$300 million in two years.
He was Marketing Director & Deputy General Manager of GE Healthcare’s Infrastructure Solutions division, based in Istanbul and responsible for all aspects of the healthcare infrastructure market in Russia, Turkey, Central Asia, the Middle East and Africa, including technology fleet management, clinical service-line development, turnkey projects and Healthcare Public/Private Partnerships (“PPP”).
Paul has over 25 years experience in healthcare. He is a dynamic and successful global leader, with a demonstrable track record in strategy, finance, business development, sales & marketing, risk management and operations.
Paul Christie Chief Operating Officer
Paul has had a twenty-three-year career in the City as an executive in blue chip financial institutions and international business. He is a visionary and creative entrepreneur, with a successful track record advising and fund raising for hedge and private equity businesses.
Paul has first-hand experience of the challenges and rewards from investing internationally across the value chain in complex, cross-border operational businesses. He has a passion for global macro-economics and geopolitics which has underpinned his specialist interest in themes such as healthcare in frontier/emerging markets (notably Africa).
He is the founder of ARACAP International Limited, a business advisor based in the United Kingdom. ARACAP uses its focus on frontier and emerging markets to identify and pioneer new business models and disruptive technologies in developing operational businesses in traditional sectors. His thesis is that successful innovations derived from transformative challenges found in the new world will have wider significance in more mature markets.
Paul was previously the head of Business Development and an executive committee member of Emergent Asset Management. Whilst at Emergent, Paul led financing and restructuring of projects in energy, agriculture and business restructuring including developing new macro and emerging market funds in compliance. In this role Paul was a founding member of the World Bank's committee for responsible investment in agriculture.
Prior to Emergent, Paul was the Head of Business Development for ILEX Asset Management, a European long short credit hedge fund. He was a business development executive for securities financing at the Deutsche Boerse Group. After leaving his role as a product manager in JP Morgan’s credit & exotic derivatives group in London he concentrated on developing business opportunities in alternative investments through hedge and private equity strategies.
Paul is fluent in French, has a BA (Hons) in Business in Europe from the Manchester Metropolitan University and a Maitrise in International Business from the Universite Savoie Mont Blanc.
Gordon McIvor Wilson Business Development Director
Gordon McIvor Wilson is the founder of Radley Pharma Ltd, (Thorn Medical subsidiary company) a life sciences and healthcare business commercialising science and technology.
He has extensive experience of forming, building and valuing technology businesses.
He qualified as a chartered accountant (KPMG) and has served on public and private company boards over 30 years. Gordon brings a lifetime of business experience to the company ,
Sir Eric Peacock Non-Executive Director
Sir Eric Peacock has a wide range of interesting business experience having taken Babygro Plc to a full market listing and Baydonhill Plc to a full AIM listing and Just Loans Plc to a GHG Listing.
He is Chairman of Buckley Jewellery Ltd, Halo International (Hong Kong), Boxford Holdings and between these businesses they had subsidiaries in USA and Hong Kong.
Eric is also a Non Executive Director of the government body UK Export Finance(formerly ECGD) and chairs the charities Uniqueness, AB Trust and The Peacock Foundation.
He has worked in New Zealand, Australia, USA, Hong Kong and Ireland in a wide range of industries.
Jack Kaye Non-Executive Director
With over 40 years business experience, Jack established one of the first mobile phone network resellers in 1984 - his company was eventually sold to Hutchison Whampoa and formed the basis of what became the Orange mobile phone network in the UK.
He has a history of developing a number of successful businesses and holds Executive positions including that of CEO, on the boards of a number of Private and Public Limited Companies in both Europe and North America.
He is a member of the Committee on Advanced Technology for the USA based International Charity, The Cure is Now which is committed to funding and supporting the highest quality research that has the greatest potential to make a significant impact on the scientific community and patients throughout the world.